Stomach cancer incidence statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of stomach cancer, 2015-2017, UK

 

Proportion of all cases

Percentage stomach cancer is of total cancer cases, 2015-2017, UK

 

Age

Peak rate of stomach cancer cases, 2015-2017, UK

 

Trend over time

Change in stomach cancer incidence rates since the early 1990s, UK

 

Stomach cancer is the 17th most common cancer in the UK, accounting for 2% of all new cancer cases (2017).[1-4]

In females in the UK, stomach cancer is the 19th most common cancer (1% of all new female cancer cases). In males in the UK, it is the 13th most common cancer (2% of all new male cancer cases).

35% of stomach cancer cases in the UK are in females, and 65% are in males.

Stomach cancer incidence rates (European age-standardised (AS) rates Open a glossary item) for persons are significantly higher than the UK average in Scotland, Wales and Northern Ireland, and similar to the UK average in England.

Stomach Cancer (C16), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2017

  England Scotland Wales Northern Ireland UK
Female Cases 1,764 245 130 77 2,216
Crude Rate 6.3 8.8 8.2 8.1 6.6
AS Rate 6.2 8.4 7.4 8.8 6.6
AS Rate - 95% LCL 5.9 7.4 6.1 6.8 6.3
AS Rate - 95% UCL 6.5 9.5 8.7 10.8 6.8
Male Cases 3,378 372 285 112 4,147
Crude Rate 12.3 14.1 18.5 12.2 12.7
AS Rate 14.4 16.3 19.3 15.3 14.9
AS Rate - 95% LCL 13.9 14.6 17.0 12.5 14.4
AS Rate - 95% UCL 14.9 17.9 21.5 18.1 15.3
Persons Cases 5,142 617 415 189 6,363
Crude Rate 9.2 11.4 13.3 10.1 9.6
AS Rate 9.9 11.8 12.8 11.8 10.3
AS Rate - 95% LCL 9.7 10.9 11.6 10.1 10.0
AS Rate - 95% UCL 10.2 12.8 14.1 13.5 10.5

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item
 

For stomach cancer, like most cancer types, differences between countries largely reflect risk factor prevalence in years past.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C16.

Last reviewed:

Stomach cancer incidence is strongly related to age, with the highest incidence rates being in older people.

In the UK in 2015-2017, on average each year around half of new cases (51%) were in people aged 75 and over.[1-4]

Age-specific incidence rates rise steadily from around age 45-49 and more steeply from around age 65-69.The highest rates are in in the 85 to 89 age group for females and males.

Incidence rates are significantly lower in females than males in a number of (mainly older) age groups.The gap is widest at age 65 to 69, when the age-specific incidence rate is 2.6 times lower in females than males.

Stomach cancer (C16), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Population, UK, 2015-2017

For stomach cancer, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, C16.

Last reviewed:

Stomach cancer European age-standardised (AS) incidence rates for females and males combined decreased by 53% in the UK between 1993-1995 and 2015-2017.[1-4] The decrease was of a similar size in females and males.

For females, stomach cancer AS incidence rates in the UK decreased by 53% between 1993-1995 and 2015-2017. For males, stomach cancer AS incidence rates in the UK decreased by 55% between 1993-1995 and 2015-2017.

Over the last decade in the UK (between 2005-2007 and 2015-2017), stomach cancer AS incidence rates for females and males combined decreased by 29%. In females AS incidence rates decreased by 28%, and in males rates decreased by 32%.

Stomach Cancer (ICD-10 C16), European Age-Standardised Incidence Rates, UK, 1993-2017

Stomach cancer incidence rates have decreased overall in most broad age groups in females and males combined in the UK since the early 1990s, but have remained stable in some.[1-4] Rates in 0-24s have remained stable, in 25-49s have decreased by 29%, in 50-59s have decreased by 49%, in 60-69s have decreased by 60%, in 70-79s have decreased by 54%, and in 80+s have decreased by 50%.

Stomach Cancer (ICD-10 C16), European Age-Standardised Incidence Rates, By Age, UK, 1993-2017

For stomach cancer, like most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1993-2017, ICD-10 C16.

Last reviewed:

Overall stage at diagnosis

A moderate proportion (62-73%) of stomach cancer cases in England, Scotland and Northern Ireland have stage at diagnosis recorded.[1-3]

Stomach cancer patients with a known stage are most commonly diagnosed at stage IV (46-57%). More patients with a known stage are diagnosed at a late stage (69-75% are diagnosed at stage III or IV), than an early stage (25-31% are diagnosed at stage I or II).[1-3]

The stage distribution for each cancer type will reflect many factors including how the cancer type develops, the way symptoms appear, public awareness of symptoms, how quickly a person goes to see their doctor and how quickly the cancer is recognised and diagnosed by a doctor. It might also relate to whether a national screening programme that can detect early stage disease exists for that cancer type, along with the extent of uptake of that programme.

A cancer type associated with a large proportion of early stage diagnoses could be one that is more likely to be symptomatic at an earlier stage of development, with recognisable symptoms rather than more generic ones.

Stomach Cancer (C16), Proportion of Cases Diagnosed at Each Stage, All Ages, England 2014, Scotland 2014 and Northern Ireland 2010-2014

Data should not be compared between countries due to possible differences in recording of stage at diagnosis.

References

  1. National Cancer Registration and Analysis Service. Stage Breakdown by CCG 2014. London: NCRAS; 2016.
  2. ISD Scotland, Detect Cancer Early Staging Data. Scotland: ISD; 2016.
  3. Northern Ireland Cancer Registry, Queens University Belfast, Incidence by stage 2010-2014. Belfast: NICR; 2016.

About this data

Data is for: England 2014, Scotland 2014, Northern Ireland 2010-2014, ICD-10 C16

Data is not comparable between countries due to differences in time periods and possible differences in how countries record stage at diagnosis.

Last reviewed:

The largest proportion of stomach cancer cases occur in the cardia, with much smaller proportions in the pyloric antrum and body of the stomach (2010-2012).[1-4]

The proportion of cases in the cardia is higher in males (34.0%) than females (19.7%) and there are no marked sex differences in other parts of the stomach.[1-4]

A large proportion of cases did not have the specific part of the stomach recorded in cancer registry data, or overlapped more than one part.[1-4]

Cases and percentages may not sum due to rounding

References

  1. Data were provided by the Office for National Statistics on request, July 2014. Similar data can be found here: http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations--england--series-mb1-/index.html.
  2. Data were provided by ISD Scotland on request, April 2014. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit on request, April 2014. Similar data can be found here: http://www.wales.nhs.uk/sites3/page.cfm?orgid=242&pid=59080.
  4. Data were provided by the Northern Ireland Cancer Registry on request, June 2014. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/CancerInformation/.

About this data

Data is for: UK, 2010-2012, ICD-10 C16

Last reviewed:

Stomach cancer incidence rates are projected to fall by 17% in the UK between 2014 and 2035, to 11 cases per 100,000 people by 2035.[1] This includes a larger decrease for males than for females.

For males, stomach cancer European age-standardised (AS) Open a glossary item incidence rates in the UK are projected to fall by 23% between 2014 and 2035, to 15 cases per 100,000 by 2035.[1] For females, rates are projected to fall by 9% between 2014 and 2035, to 8 cases per 100,000 by 2035.[1]

Stomach cancer (C16), Observed and Projected Age-Standardised Incidence Rates, by Sex, UK, 1979-2035

It is projected that 8,282 cases of stomach cancer (5,220 in males, 3,062 in females) will be diagnosed in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C16

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

Stomach cancer incidence rates (European age-standardised (AS) rates Open a glossary item) in England in females are 99% higher in the most deprived quintile compared with the least, and in males are 84% higher in the most deprived quintile compared with the least (2013-2017).[1]

It is estimated that there are around 1,300 more cases of stomach cancer each year in England than there would be if every deprivation quintile had the same age-specific crude incidence rates as the least deprived quintile. Around 490 of these cases are in females, and around 830 in males.

In the text above, males and females’ excess cases do not sum to persons excess cases due to rounding

Stomach Cancer (C16), Estimated Average Number of Excess Cases per Year and European Age-Standardised Incidence Rates per 100,000 Population, by Deprivation Quintile, England, 2013-2017

References

  1. Calculated by the Cancer Intelligence Team at Cancer Research UK, April 2020. Based on method reported in National Cancer Intelligence Network Cancer by Deprivation in England Incidence, 1996-2010 Mortality, 1997-2011 . Using cancer incidence data 2013-2017 (Public Health England) and population data 2013-2017 (Office for National Statistics) by Indices of Multiple Deprivation 2015 income domain quintile, cancer type, sex, and five-year age band.

About this data

Data is for England, 2013-2017, ICD-10 C16.

Last reviewed:

Age-standardised rates for White males with stomach cancer range from 14.1 to 14.7 per 100,000. Rates for Asian males are significantly lower, ranging from 5.2 to 8.5 per 100,000 whereas rates for Black males are significantly higher, ranging from 16.1 to 25.6 per 100,000. For females there is a similar pattern - the age-standardised rates for White females range from 5.5 to 5.8 per 100,000, while rates for Asian females are significantly lower, ranging from 2.7 to 5.0 per 100,000, and the rates for Black females are significantly higher ranging from 6.5 to 11.9 per 100,000.[1]

Ranges are given because of the analysis methodology used to account for missing and unknown data. For stomach cancer, 33,789 cases were identified; 18% had no known ethnicity.

References

  1. National Cancer Intelligence Network and Cancer Research UK. Cancer Incidence and Survival by Major Ethnic Group, England, 2002-2006. 2009.

About this data

Data is for: England, 2002-2006, ICD10-C16

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.